R

Cartesian Therapeutics
D

RNAC

10.365
USD
0.31
(3.08%)
مفتوح الان
حجم التداول
2,338
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
313,596,723
المقالات
المزيد

العنوان: Cartesian Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.